Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

HelpMeSee’s Mazava Project trains general practitioners in Madagascar to perform cataract surgeries, addressing the country’s ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

Prevent Blindness has designated November 18 to 24, 2024, as the 5th annual Thyroid Eye Disease (TED) Awareness Week. The ...

HelpMeSee has partnered with new initiatives to address the global cataract blindness crisis, focusing on empowering women in ...

Program director and co-founder Bonnie An Henderson, MD, sits down with Ophthalmology Times to talk about how the annual ...

NEI Initiative aims to boost awareness, standardize diagnosis, and improve care for children with CVI through multidisciplinary collaboration and emerging technologies.

Cataract blindness affects over 100 million people globally, creating a significant socioeconomic burden, especially in low-income populations lacking surgical care access. HelpMeSee's ...

CVI is a major cause of childhood vision loss, requiring early intervention and multidisciplinary management for effective treatment and support. The NEI's initiative focuses on raising awareness, ...